Search results for "covid-19"
Article
EMA Confirms Standards for COVID-19 Treatment Evaluations
30, 2020, detailing the agency’s transparency plans for COVID-19 treatments and affirming its commitment to independence in the evaluation of COVID-19 treatments and vaccines. The letter was in respon…
Article
EMA Guidance on Changes to COVID-19 Vaccines to Fight Variants
The European Medicines Agency (EMA) has requested that developers determine if their COVID-19 vaccines protect against new virus mutations that have been identified in the United Kingdom, South Africa…
Article
Ajinomoto Bio-Pharma Services, CytoDyn in Manufacturing Partnership for COVID-19 Drug
It has been and is currently being administered to COVID-19 patients at New York City area hospitals as part of an emergency investigational new drug (EIND), granted by FDA as part of Phase I, Phase I…
Article
Lessons Learned from the Biopharma Industry's Response to the COVID-19 Pandemic
pandemic
Click here to view more Industry Leader Q&As >>
James Blackwell, President, Windshire Group, LLC, discusses the biopharma industry’s response to the COVID-19 pandemic a…
Article
COVID-19 Diagnostics Supplier Ramps Up Production with Help of Cytiva’s Testa Center in Sweden
CONTINUE READING >>
In this blog post, you can learn about how Solis BioDyne, Estonian manufacturer of polymerase chain reaction/quantitative polymerase chain reaction reagents to analyze DNA f…
Article
Maximum Output Starts with Optimized Upstream Processing
…s, and cell, gene, and gene-editing therapies—was occurring worldwide before the emergence of the COVID-19 pandemic. Demand for biosimilars is also increasing. The requirements associated with COVID-…
Article
Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
By Cynthia A. Challener
MONGKOLCHON - STOCK.ADOBE.COM
…
Article
Remote Monitoring and Big Data Advance Upstream Automation
The COVID-19 pandemic has only accelerated these trends.
Bringing flexibility and increased process intelligence
Upstream bioprocess manufacturing is being discussed from many different angles…
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Through its Operation Warp Speed program for COVID-19 vaccine manufacturing, the US government is paying manufacturers and contract service providers to scale up the manufacture of specific vaccine ca…
Article
Genetic Vaccine Platforms Demonstrate Their Potential
…tions with the same or a different vaccine may be applied, which is what we’re seeing in the mRNA COVID-19 vaccines,” he says.
Indeed, while genetic vaccines hold much promise, t…